MacuSight

Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema.

Get a Demo and See the Full Profile

Get a demo today to see profiles of MacuSight plus 6035 other startups.

Learn More About MacuSight

Technology/product details

Competing Startups

More